These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37159421)

  • 21. Prokinetics for functional dyspepsia.
    Pittayanon R; Yuan Y; Bollegala NP; Khanna R; Leontiadis GI; Moayyedi P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009431. PubMed ID: 30335201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.
    Brown CK; Khanderia U
    Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular safety profile and clinical experience with high-dose domperidone therapy for nausea and vomiting.
    Ortiz A; Cooper CJ; Alvarez A; Gomez Y; Sarosiek I; McCallum RW
    Am J Med Sci; 2015 May; 349(5):421-4. PubMed ID: 25828198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic response to domperidone in gastroparesis: A prospective study using the GCSI-daily diary.
    Heckert J; Parkman HP
    Neurogastroenterol Motil; 2018 Jan; 30(1):. PubMed ID: 29110425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prokinetic agents--their contribution to practice of gastroenterology].
    Hep A; Dolina J
    Vnitr Lek; 2011 Sep; 57(9):693-6. PubMed ID: 21957760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group.
    Silvers D; Kipnes M; Broadstone V; Patterson D; Quigley EM; McCallum R; Leidy NK; Farup C; Liu Y; Joslyn A
    Clin Ther; 1998; 20(3):438-53. PubMed ID: 9663360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical evaluation of antiemetics for vomiting due to cancer chemotherapy in children].
    Ise T; Ohira M; Omiya A; Hirose M; Shibata T
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1108-18. PubMed ID: 6764113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should domperidone be used for the treatment of gastro-oesophageal reflux in children? Systematic review of randomized controlled trials in children aged 1 month to 11 years old.
    Pritchard DS; Baber N; Stephenson T
    Br J Clin Pharmacol; 2005 Jun; 59(6):725-9. PubMed ID: 15948939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some possible gynaecological indications for peripheral antidopamine therapy.
    Varga A; Lovas J
    Ther Hung; 1992; 40(1):28-30. PubMed ID: 1585281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Question 2. How effective is domperidone at reducing symptoms of gastro-oesophageal reflux in infants?
    Scott B
    Arch Dis Child; 2012 Aug; 97(8):752-5. PubMed ID: 22859430
    [No Abstract]   [Full Text] [Related]  

  • 31. Review of the current status of prokinetic agents in gastroenterology.
    McCallum RW
    Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997
    [No Abstract]   [Full Text] [Related]  

  • 32. Domperidone to Treat Symptoms of Gastroparesis: Benefits and Side Effects from a Large Single-Center Cohort.
    Schey R; Saadi M; Midani D; Roberts AC; Parupalli R; Parkman HP
    Dig Dis Sci; 2016 Dec; 61(12):3545-3551. PubMed ID: 27530760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-emetics.
    MacGregor EA
    Curr Med Res Opin; 2001; 17 Suppl 1():s22-5. PubMed ID: 12463273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride.
    Halter F; Staub P; Hammer B; Guyot J; Miazza BM
    J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Domperidone induced galactorrhea: an unusual presentation of a common drug.
    Poovathingal MA; Bhat R; Ramamoorthi
    Indian J Pharmacol; 2013; 45(3):307-8. PubMed ID: 23833383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical Evaluation of the Effects of Trazpiroben (TAK-906), a Novel, Potent Dopamine D
    Whiting RL; Choppin A; Luehr G; Jasper JR
    J Pharmacol Exp Ther; 2021 Oct; 379(1):85-95. PubMed ID: 34253646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Domperidone.
    Nurs Times; 2005 Feb 15-21; 101(7):31. PubMed ID: 15759520
    [No Abstract]   [Full Text] [Related]  

  • 38. Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis.
    Yang YJ; Bang CS; Baik GH; Park TY; Shin SP; Suk KT; Kim DJ
    BMC Gastroenterol; 2017 Jun; 17(1):83. PubMed ID: 28651565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of domperidone therapy on symptoms and upper gastrointestinal motility in infants with gastroesophageal reflux.
    Grill BB; Hillemeier AC; Semeraro LA; McCallum RW; Gryboski JD
    J Pediatr; 1985 Feb; 106(2):311-6. PubMed ID: 3968623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical guideline: management of gastroparesis.
    Camilleri M; Parkman HP; Shafi MA; Abell TL; Gerson L;
    Am J Gastroenterol; 2013 Jan; 108(1):18-37; quiz 38. PubMed ID: 23147521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.